Daniel Kim
@ProfDanielKim
Followers
4K
Following
26K
Media
371
Statuses
4K
Assistant Professor @BaskinEng @UCSC | Associate Member @CanaryCenter @Stanford | Research Scholar @AmericanCancer | Chair, Media & Communications @RNASociety
San Francisco Bay Area
Joined April 2016
Super excited to share our latest work on #RNA liquid biopsy via @nanopore sequencing for novel biomarker discovery and #cancer early detection! https://t.co/HJl8vxbqGx Thank you @AmericanCancer @ACS_Research for supporting our research!
2
14
33
Delighted to be featured on @TheLancet podcast sharing our findings from our recent BE surveillance paper published in the Lancet! Tune in wherever you get your podcasts: https://t.co/NV6weZxEeM
#podcast #surveillance #barretts
2
7
34
Super excited to share our latest work on #RNA liquid biopsy via @nanopore sequencing for novel biomarker discovery and #cancer early detection! https://t.co/HJl8vxbqGx Thank you @AmericanCancer @ACS_Research for supporting our research!
2
14
33
RNA liquid biopsy via nanopore sequencing for novel biomarker discovery and cancer early detection https://t.co/Pu1o3mZP8l
#biorxiv_genomic
biorxiv.org
Liquid biopsies detect disease noninvasively by profiling cell-free nucleic acids that are secreted into the circulation. However, existing methods exhibit low sensitivity for detecting early stages...
0
6
10
This work was spearheaded by two amazing grad students, co-first authors Vikas Peddu & Alex Hill, with significant contributions from Sreelakshmi Velandi Maroli & Connor Mattingly, as well as our wonderful collaborators Joshua Gardner, Karen Miga, and Rebecca Fitzgerald!
0
0
3
Our study highlights the utility of our long-read sequencing-based RNA liquid biopsy approach for discovering and targeting early stages of disease with molecular precision.
1
0
3
Through our LOCATE-seq RNA liquid biopsy platform technology, we also discovered potential therapeutic targets, including metabolic, signaling, and immune checkpoint pathways, that are highly upregulated in both precancer and cancer patients.
1
1
1
Using these novel, unannotated cell-free RNAs, we built a custom transcriptome reference for quantification, feature selection, and machine learning to accurately classify both precancerous Barrett's esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma.
1
0
1
We leveraged the power of single-molecule, long-read sequencing of cell-free RNA using Oxford Nanopore Technologies' PromethION platform to discover over 270,000 novel, intergenic cell-free RNAs.
1
0
0
A new study shows how Oxford Nanopore sequencing of cell-free RNA can distinguish healthy, precancerous, and cancerous states — unlocking powerful new insights for precision oncology. https://t.co/t1o8JnZocy
1
5
12
Join us in the fight against cancer! Please consider making a gift today to advance the future of cancer early detection & to support the next generation of cancer researchers! https://t.co/uG2REs7nJG
10
36
123
Join us in the fight against cancer! Please consider making a gift today to advance the future of cancer early detection & to support the next generation of cancer researchers! https://t.co/uG2REs7nJG
10
36
123
Register today for RNA 2025 - the 30th Annual Meeting of the RNA Society! This year’s meeting will be held at the beautiful Town and Country Resort & Convention Center in sunny San Diego, California, USA from May 27th - June 1st, 2025 https://t.co/ku0eHmxY06 Poster presentation
2
10
23
We are pleased to announce registration for RNA 2025 - the 30th Annual Meeting of the RNA Society - is now open! https://t.co/ku0eHmxY06 This year’s meeting will be held at the beautiful Town and Country Resort & Convention Center in sunny San Diego, California, USA from May
1
22
67
SCI member @cncurtis & others found #BreastCancer spans three genomic archetypes: ER+ high-risk tumors with complex amplifications (ecDNA), HRD-like TNBC, and stable ER+ typical-risk tumors. These suggest new treatment targets, like PARP inhibitors. https://t.co/GlKzAoFnco
0
5
19
Next Wave of Faculty in Genomics Symposium UC Santa Cruz is hosting a symposium dedicated to celebrating & highlighting outstanding genomic research of diverse postdoctoral fellows across the country on April 15, 2025. @RussCorbett
https://t.co/5ysf8oyKGQ
docs.google.com
UC Santa Cruz is pleased to be hosting a symposium dedicated to celebrating and highlighting the outstanding genomic research of diverse postdoctoral fellows across the country. The Next Wave of...
0
3
6
Noncoding RNA has increasingly intrigued scientists as a diagnostic and prognostic tool for cancer. In this webinar, Daniel Kim will discuss how he developed RNA liquid biopsy technology for early cancer detection. Register now: https://t.co/6huCGYCdl1
0
3
4
We are excited to announce that the RNA 2025 Annual Meeting website is live! #RNA25
https://t.co/ku0eHmxY06 Limited rooms are available at a special RNA 2025 rate to stay at the beautiful Town and Country Resort & Convention Center, so please book today! https://t.co/BKtuHacSzG
3
27
94
Later on today we'll be hearing from 3 liquid biopsy researchers as they portray the latest research in detectable #biomarkers. @ProfDanielKim will be presenting a valuable session on RNA #liquidbiopsy technology and nanopore sequencing. Register here - https://t.co/SVOjQoanCA
0
4
4
Did you see our #liquidbiopsy webinar series? Join us next week to move beyond theory into practical advice, guided by 9 expert speakers e.g. @antoniagage, @drmatthewmurray, @AlastairGreyst2, @StefaniaCrucit1,@ProfDanielKim & @ShervinTabrizi. Register Now! https://t.co/KcT9BFGKki
0
3
4